Your browser doesn't support javascript.
loading
Alteration of serum bile acid profiles of HBV-related hepatocellular carcinoma identified by LC-MS/MS.
Dai, Sijia; Zhu, Jingfei; Chen, Xuqiong; Zheng, Liming; Li, Xiaoping; Liu, Longgen.
Afiliação
  • Dai S; Changzhou Clinical Medical College, Nanjing Medical University, 300 Lanling Road, Changzhou City, 213001, Jiangsu, China.
  • Zhu J; Clinical Lab, Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, 213001, China.
  • Chen X; Changzhou Clinical Medical College, Nanjing Medical University, 300 Lanling Road, Changzhou City, 213001, Jiangsu, China.
  • Zheng L; Clinical Lab, Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, 213001, China.
  • Li X; Clinical Lab, Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, 213001, China. 3406966332@qq.com.
  • Liu L; Changzhou Clinical Medical College, Nanjing Medical University, 300 Lanling Road, Changzhou City, 213001, Jiangsu, China. ssewllg@163.com.
J Cancer Res Clin Oncol ; 150(3): 157, 2024 Mar 25.
Article em En | MEDLINE | ID: mdl-38528272
ABSTRACT

BACKGROUND:

Hepatocellular carcinoma closely related to metabolic disorders is a common and aggressive liver malignancy. The dysregulation of bile acid homeostasis has emerged as a key factor for the development and progression of HCC. We aimed to investigate the relationship between bile acids and HCC diagnosis and progression.

METHODS:

A total of 744 HBV-related patients (including 396 HCC patients and 348 patients with chronic liver diseases) were enrolled in the current study. The baseline characteristics of patients were collected from electronic medical records, and the levels of bile acid profiles were determined by LC-MS/MS. Propensity score matching analysis was conducted to reduce the effect of selection bias, and receiver operating characteristic analysis was performed to evaluate the clinical application values of bile acid.

RESULTS:

Significant differences were observed for most characteristics between the HCC group and the CLD group before PSM analysis. Patients with HCC were older and fatter (p < 0.05). After adjusting with a 11 ratio for age, gender and BMI, 42 HCC patients and 42 non-HCC patients were matched in 2 groups, respectively. The total bile acid level in HCC patients was lower than that in patients with chronic liver diseases before and after PSM analysis (p < 0.05). However, patients with HCC had significantly higher levels of DCA, LCA, and GLCA and lower levels of TCDCA, GUDCA, and TUDCA (p < 0.05, respectively). Besides, the TCDCA, TUDCA, GLCA, and GUDCA were significantly correlated with tumor procession. Moreover, the BAs profiles had a superior predictive ability for predicting the development of HCC even in patients with low serum AFP levels.

CONCLUSION:

Patients with HCC had significantly lower levels of total bile acid, but higher levels of secondary bile acids (DCA, LCA, and GLCA). The levels of primary bile acid (TCDCA) were closely related to tumor size and stage, which indicated that the bile acids were involved in the HCC procession and had important clinical application values.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácido Tauroquenodesoxicólico / Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácido Tauroquenodesoxicólico / Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2024 Tipo de documento: Article